Globe Biotech Limited submits a protocol to Bangladesh Medical Research Council (BMRC) for ethical approval to conduct the clinical trial of their vaccine Bangavax. "Principal investigator of the clinical trial Prof Mamun Al Mahtab informed us that we would be able to start the human trial within seven to 10 days after the protocol approval. Also Read - Globe Biotech gets permission to manufacture Covid-19 vaccine for trialEarlier on December 28 last year, the Directorate General of Drug Administration (DGDA) gave permission to Globe Biotech to manufacture Bangavax for clinical trials. Globe Biotech cancelled the memorandum of understanding (MoU) as they observed less progress in icddr,b's approach to conducting the human trials. On July 2, claiming success in preliminary animal modelling trials for Covid-19 vaccine, Globe Biotech claimed to be the first company from Bangladesh to have a Covid-19 vaccine under development.

Source: Dhaka Tribune January 17, 2021 03:27 UTC